Atıf İçin Kopyala
Oztaner S. M., Temizel T., Erdem S. R., ÖZER M.
IEEE JOURNAL OF BIOMEDICAL AND HEALTH INFORMATICS, cilt.19, sa.5, ss.1724-1733, 2015 (SCI-Expanded)
-
Yayın Türü:
Makale / Tam Makale
-
Cilt numarası:
19
Sayı:
5
-
Basım Tarihi:
2015
-
Doi Numarası:
10.1109/jbhi.2014.2336974
-
Dergi Adı:
IEEE JOURNAL OF BIOMEDICAL AND HEALTH INFORMATICS
-
Derginin Tarandığı İndeksler:
Science Citation Index Expanded (SCI-EXPANDED), Scopus
-
Sayfa Sayıları:
ss.1724-1733
-
Anahtar Kelimeler:
Bayesian structural equation modeling, data mining, personalized medicine, pharmacogenomics, STRUCTURAL EQUATION MODELS, GENETIC-POLYMORPHISM, ATRIAL-FIBRILLATION, CLINICAL FACTORS, VKORC1, CYP2C9, IMPACT, ANTICOAGULATION, HAPLOTYPES, ALGORITHM
-
Orta Doğu Teknik Üniversitesi Adresli:
Evet
Özet
The incorporation of pharmacogenomics information into the drug dosing estimation formulations has been shown to increase the accuracy in drug dosing and decrease the frequency of adverse drug effects in many studies in the literature. In this paper, an estimation framework based on the Bayesian structural equation modeling, which is driven by pharmacogenomics, is proposed. The results show that the model compares favorably with the linear models in terms of prediction and explaining the variations in warfarin dosing.